NCT03567616 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03567616
Title	A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Recruitment	Terminated
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	AbbVie
Indications	multiple myeloma
Therapies	Dexamethasone + Pomalidomide + Venetoclax
Age Groups:	senior \| adult
Covered Countries	USA \| GBR \| ESP

Filter rows:

Showing 1 to 11 of 11 entries

Facility	City	State	Zip	Country	Details
Duke University Hospital /ID# 200805	Durham	North Carolina	27710	United States	Details
Hospital Clinico Universitario de Salamanca /ID# 200958	Salamanca		37007	Spain	Details
Hospital Universitario Germans Trias i Pujol /ID# 200959	Badalona	Barcelona	08916	Spain	Details
Hospital Universitario Vall d'Hebron /ID# 200967	Barcelona		08035	Spain	Details
John B. Amos Cancer Center - C /ID# 202055	Columbus	Georgia	31904	United States	Details
Leicester Royal Infirmary /ID# 202238	Leicester	England	LE1 5WW	United Kingdom	Details
Norfolk and Norwich Univ Hosp /ID# 202240	Norwich	Norfolk	NR4 7UY	United Kingdom	Details
Ohio State Cancer Center /ID# 202443	Columbus	Ohio	43210	United States	Details
Univ Hospitals Birmingham NHS Foundation trust /ID# 203188	Birmingham		B15 2TG	United Kingdom	Details
University of Kansas Cancer Center /ID# 201292	Fairway	Kansas	66205-2528	United States	Details
Washington University-School of Medicine /ID# 201287	Saint Louis	Missouri	63110	United States	Details

Showing 1 to 11 of 11 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT03567616Clinical Trial Detail